GlassScriptPhysician profile
Kamel Shibbani
NPI 1538693700
$5,385.46
in general payments reported to CMS, 2019-2025
8 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $36.32 · 2023: $751 · 2024: $4,230 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,674 · Food and Beverage: $2,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,674.23 |
| Food and Beverage | $2,474.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,933.58 | 2024 | Impella |
| Edwards Lifesciences Corporation | $1,382.10 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Medtronic, INC. | $1,341.74 | 2021-2025 | Harmony, Melody Tpv |
| Abbott Laboratories | $422.00 | 2023-2024 | Amplatzer Piccolo, Piccolo Xpress, Perclose Proglide |
| W. L. Gore & Associates, INC. | $170.55 | 2024 | Gore Cardioform Septal Occluder |
| Atrility Medical, INC. | $56.05 | 2023 | Atriamp |
| Boston Scientific Corporation | $43.80 | 2023 | Latitude Communicator Power Supply |
| Merit Medical Systems INC | $35.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamel Shibbani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.